美国 2019-2020 年肺癌发病率:COVID-19 大流行的潜在影响。
Lung Cancer Incidence, 2019-2020, United States: The Potential Impact of the COVID-19 Pandemic.
发表日期:2024 Aug 26
作者:
Christine M Kava, David A Siegel, Susan A Sabatino, Jin Qin, Thomas B Richards, S Jane Henley
来源:
ANNALS OF EPIDEMIOLOGY
摘要:
COVID-19 大流行期间癌症发病率下降,部分原因是医疗保健服务面临挑战。我们研究了 COVID-19 大流行对肺癌发病率变化的影响。我们使用了 49 个癌症登记处的 2019-2020 年美国癌症统计数据,覆盖了美国人口的 97%。我们计算了 2019 年和 2020 年新诊断肺癌的数量、每 10 万人中年龄调整后的肺癌发病率,以及 2019 年至 2020 年发病率的百分比变化。我们还按月份和诊断时的分期计算了新诊断肺癌的数量和百分比。每 10 万人中年龄调整后的肺癌发病率为 2019 年的 47.9 例,而 2020 年为 41.4 例,下降了 13.6%。根据年龄、种族和民族、美国人口普查地区、组织学和诊断分期观察到发病率百分比变化的差异。与 2019 年相比,2020 年被诊断为远期癌症的人数比例更高。该报告对在 COVID-19 大流行的第一年中观察到的肺癌发病率下降幅度最大的亚组提供了新的见解。研究结果可用于为改善肺癌筛查、诊断和治疗的干预措施提供信息。版权所有 © 2024。由 Elsevier Inc. 出版。
Cancer incidence declined during the COVID-19 pandemic in part due to health care delivery challenges. We examined the impact of the COVID-19 pandemic on changes in lung cancer incidence.We used 2019-2020 US Cancer Statistics data from 49 cancer registries covering 97% of the US population. We calculated the number of new lung cancer diagnoses in 2019 and 2020, age-adjusted lung cancer incidence rates per 100,000 persons, and 2019-to-2020 percentage changes in incidence rates. We also calculated number and percentage of new lung cancer diagnoses by month and stage at diagnosis.The age-adjusted lung cancer incidence rate per 100,000 persons was 47.9 in 2019 vs. 41.4 in 2020-a 13.6% decrease. Differences in the percentage change in incidence rates were observed by age, race and ethnicity, US census region, histology, and stage at diagnosis. A higher percentage of people were diagnosed at distant stage in 2020 than 2019.This report provides new insight into subgroups that experienced the greatest decline in observed lung cancer incidence during the first year of the COVID-19 pandemic. The findings can be used to inform intervention efforts to improve lung cancer screening, diagnosis, and treatment.Copyright © 2024. Published by Elsevier Inc.